Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Donald Trump
Biotech
Biophama VC, deal values and exits all rise in Q3: Pitchbook
Biopharma brought in $7.2 billion across 187 deals in 2024's third quarter, jumping from $5.8 billion in the second quarter.
Gabrielle Masson
Nov 20, 2024 6:15am
What medtech CEOs are saying about Trump's potential tariffs
Nov 8, 2024 11:48am
Biden and biotech: Science first
Jan 20, 2021 9:00am
Fierce Biotech's Top 10 stories of 2020—COVID and more COVID
Dec 23, 2020 7:30am
Looking ahead to 2021: A year that will be shaped the pandemic
Dec 22, 2020 7:00am
Hahn heads toward FDA exit after short, dramatic tenure
Dec 22, 2020 7:00am